Hematology-Oncology Clinics of North America

Article	Citations
Chronic Lymphocytic Leukemia	69
Contents	64
Advanced Melanoma	52
Forthcoming Issues	51
Forthcoming Issues	46
Contributors	35
Conflict and Access to Health Care	30
Impact of Clonal Heterogeneity in Multiple Myeloma	27
FLASH Radiotherapy	26
The Emerging Potential of Lead-212 Theranostics	24
The New Science and Concepts That Underlie Current and Future Treatments for Myeloproliferative Neoplasms	23
Patient, Caregiver, and Provider Well-Being in Oncology	23
Early and Late Toxicities of Chimeric Antigen Receptor T-Cells	21
Immune Checkpoint Therapies for Melanoma	20
Future Directions in Bladder Cancer Treatment and Research—The Patient Advocates’ Perspective	20
Contributors	18
Autoimmune Hemolytic Anemia: An Old Disease with New Twists	18
Is There a Role for Immunotherapy in Central Nervous System Cancers?	17
The Cardiopulmonary Complications of Sickle Cell Disease	17
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?	16
Clinical Complications and Their Management	16
Nonsurgical Therapy for Early-Stage Lung Cancer	15
Copyright	15
Subspecialty Breast Imaging Education in Tanzania; Clinical, Infrastructure, and Logistical Paradigms for Best Practices in the Low- and Middle-Income Settings	15
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors	15

Education and Training Models for Remote Learning	14
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma	14
Copyright	13
Managing First-Line Metastatic Renal Cell Carcinoma	13
Copyright	13
Forthcoming Issues	12
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	12
A Curative DNA Code for Hematopoietic Defects	12
Targeted Therapy Innovations for Melanoma	11
Prognostic Models in Metastatic Renal Cell Carcinoma	11
Contents	11
Current Clinical Investigations in Myelofibrosis	11
New Therapies on the Horizon	11
Ductal Carcinoma In Situ	10
The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies	10
Copyright	10
Approach to the Patient with Bleeding	10
Current and Emerging Role of Antibody–Drug Conjugates in HER2-Negative Breast Cancer	10
Clinical Vignettes, Part II: Eyes, Teeth, and Bone	10
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	9
Copyright	9
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	9
Contributors	9
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	9
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	9
Copyright	8
Prognostic and Predictive Implications of Cytogenetics and Genomics	8
Central Nervous System Complications Among Oncology Patients	8
Treatment of High-Risk Gestational Trophoblastic Neoplasia	8
Genetic Modifiers of Sickle Cell Disease	8
Forthcoming Issues	8
Early Detection and Interception of Lung Cancer	8
Copyright	8
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	8
Contributors	8
Forthcoming Issues	8
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	7
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	7
Hemophilia A (Factor VIII Deficiency)	7
Murine Modeling of Myeloproliferative Neoplasms	7
The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes	7
State of Cancer Control in South America	7
Molecular Biology of Bladder Cancer	7
Biology and Treatment of HER2-Low Breast Cancer	7
Screening for Colorectal Cancer	7
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
Forthcoming Issues	6
Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?	6
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors	6

Real World Outcomes of Patients with Bladder Cancer	6
Surgical Management of Breast Cancer Liver Metastasis	6
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	6
Accelerated and Blast Phase Myeloproliferative Neoplasms	6
Targeted Therapy for Non–Small Cell Lung Cancer	6
Management of Metastatic Liver Tumors	6
Contributors	5
Cellular Therapy and Cytokine Treatments for Melanoma	5
Surgical Management of Gestational Trophoblastic Neoplasia	5
Toxicity Management of Systemic Kidney Cancer Therapies	5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	5
Thalassemia	5
Surgery for Bladder and Upper Tract Urothelial Cancer	5
Disorders of Fibrinogen and Fibrinolysis	5
What Is New in Small Cell Lung Cancer	5
Hemophilia A/B	5
Gene Therapy for Pediatric Neurologic Disease	5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	5
Erratum	5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	5
Cancer of the Larynx and Hypopharynx	5
Structural Racism and Impact on Sickle Cell Disease	5
Immune-Pathogenesis of Myeloma	4
Current Perioperative Therapy for Muscle Invasive Bladder Cancer	4
Contents	4
CAR T-Cell	4
Contents	4
Forthcoming Issues	4
Copyright	4
Colorectal Cancer	4
Advances and Opportunities in the Management of Lung Cancer	4
Advancing Effective Clinical Trial Designs for Myelofibrosis	4
Preface	4
Contributors	4
Central Nervous System Tumor Classification	4
Role of Surgery in Metastatic Renal Cell Carcinoma	4
Contents	4
Traipsing Through Muddy Waters	4
Copyright	4
Copyright	4
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	4
Contributors	4
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer	4
Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders	4
Central Nervous System Malignancies	4
Contents	4
Hematology/Oncology Clinics of North America	4
The Role of Megakaryocytes in Myelofibrosis	3
Overview of Myeloproliferative Neoplasms	3
Merkel Cell Carcinoma	3
Advances in Adjuvant and Neoadjuvant Therapy for Melanoma	3
Advances in Gastric Cancer Surgical Management	3
Dedication	3
New Therapies on the Horizon for Relapsed Refractory Multiple Myeloma	3
The Microenvironment in Myeloproliferative Neoplasms	3
Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia	3
Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution	3
Pathogenic Mechanisms in Thalassemia I	3
Cancer Precursor Syndromes and Their Detection in the Head and Neck	3
Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis	3
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art	3
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer	3
Contents	3
Fetal Hemoglobin Regulation in Beta-Thalassemia	3
Microbiome and Immunotherapy for Melanoma	3
Contents	3
Disparities in Breast Cancer Outcomes and How to Resolve Them	3
Hematopoietic Stem Cell Transplantation in Thalassemia	3
Contributors	3
Benefits and Harms of Interception and Early Detection of Cancer	2
Forthcoming Issues	2
Metastatic Liver Tumors: The Path to Disease-Free Survival	2
Gene Therapy for Inborn Errors of Immunity	2
The Epidemiology of Bladder Cancer	2
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	2
Diagnosis and Management of Molar Pregnancies	2
Advances in Surgical Techniques for Lung Cancer	2
Factor XIII Deficiency	2
Contributors	2
Emerging Paradigms in Radiation Oncology: Treatment Evolution, Mechanisms, and Patient Centric Care	2

Inherited Bleeding Disorders	2
Measurable Residual Disease and Decision-Making in Multiple Myeloma	2
Contributors	2
Early Detection of Precursor Diseases of Multiple Myeloma	2
Novel Targeted Therapies for Renal Cell Carcinoma	2
Management of Rectal Cancer	2
Copyright	2
Chronic Pain	2
Emerging Therapies in β-Thalassemia	2
Genetics and Genomics of Gestational Trophoblastic Disease	2
Forthcoming Issues	2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer	2
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia	2
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	2
Immunotherapy-associated Autoimmune Hemolytic Anemia	2
Pathogenic Mechanisms in Thalassemia II	2
Neurofibromatoses	2
Updates in the Management of Warm Autoimmune Hemolytic Anemia	2
Surgical Management of Genitourinary Cancer Liver Metastases	2
Inherited Platelet Disorders	2
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	2
Renal Cell Cancer	2
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	2
Inherited Bleeding Disorders	2
Future Directions for Gestational Trophoblastic Disease	2
Genome-Edited T Cell Therapies	2
Molecular Pathogenesis of Multiple Myeloma	2
The Gut Microbiome in Colorectal Cancer	2
Contributors	2
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	2
75 Years of Advancement in Gestational Trophoblastic Disease	2
Lip and Oral Cavity Squamous Cell Carcinoma	1
Copyright	1
Foreword	1
Contents	1
Forthcoming Issues	1
Approach to High-Risk Multiple Myeloma	1
Advances in Immunotherapy in Esophagogastric Cancer	1
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges Ahead	1
Genetics of Pancreatic Neuroendocrine Tumors	1
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	1
Advances in Systemic Therapy in Pancreatic Cancer	1
Immunotherapy	1
Gene Therapy and Gene Editing for β-Thalassemia	1
Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies	1
Combinatorial Approaches to the Treatment of Advanced Melanoma	1
Management of Bladder Cancer: The First Inning of a New Era of Rapid Advances	1
Local Therapies in Advanced Colorectal Cancer	1
Primary Central Nervous System Lymphomas	1
Adult Evans' Syndrome	1
Salivary Gland Cancers	1
Current Therapy for Metastatic Urothelial Carcinoma	1
Forthcoming Issues	1
Diagnostic Accuracy of Biomarkers and International Ovarian Tumor Analysis Simple Rules in Diagnosis of Ovarian Cancer	1
Cancer of the Oropharynx and the Association with Human Papillomavirus	1
Copyright	1
Contents	1
Esophagogastric Cancer	1
Evidence-Based Guidance for Breast Cancer Survivorship	1
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	1
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia	1
Contributors	1
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	1
Factor XI Deficiency	1
Thalassemia	1
Forthcoming Issues	1
Complications of Autoimmune Hemolytic Anemia	1
Quality of Life in Myeloproliferative Neoplasms	1
First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma	1
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	1
Contents	1
Immunotherapy and Immunomodulation in Myeloproliferative Neoplasms	1
Myeloproliferative Neoplasms	1
Immune Therapy for Chronic Lymphocytic Leukemia	1
Targeted Agents in Esophagogastric Cancer Beyond Human Epidermal Growth Factor Receptor-2	1
Acquired von Willebrand Syndrome	1
Remembering the Contributions of Professor David J. Weatherall	1
Preclinical Models for Bladder Cancer Research	1
Nevi and Melanoma	1
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	1
Breast Cancer	0
Functional Radiosurgery in the Management of Cancer Pain	0
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms	0
Copyright	0
Contributors	0
Adjuvant Therapy of Melanoma	0
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	0
Breast Cancer in India	0
Gene Signatures and Oncology Treatment Implications	0
Contributors	0
Copyright	0
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus	0
Contents	0
Patient-Reported Outcomes in Radiation Oncology	0
Renal Cell Carcinoma of Variant Histology	0